| TALETRECTINIB 
| TALETRECTINIB | ANTINEOPLASTIC TREATMENT OF NON-SMALL CELL LUNG CANCER (NSCLC) KINASE INHIBITOR | ORAL | Cmax 1.2 MICROMOLAR Tmax 4 HOUR VD 9820 LITER PPB 96 PERCENT Cl 63 LITER / HOUR HT 66 HOUR SOLUBILITY PRACTICALLY INSOLUBLE IN WATER | TYROSINE KINASE ROS1 TRKA TRKB TRKC | - more at DrugCentral | EMA ANSM (in French) Inxight Drugs Dailymed Drugs.com VigiAccess SIDER side effects Chemical Probes Portal ChEMBL BindingDB DrugBank |